EU Approves Allergan’s Eye-Drug Ozurdex

Drug Industry Daily
A A
Allergan’s drug-releasing eye implant Ozurdex picked up a new indication in the European Union this week.

To View This Article:

Login

Subscribe To Drug Industry Daily